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2511stable coronary disease has been reported, especially within
30 days (5–7). Aoki et al. (8) reported similar rates of ST in
DES and BMS (1.4%) in ACS patients within 30 days
and a lower rate of 0.3% to 0.5% in patients in stable con-
dition. The etiology of early ST (within 30 days) in DES
and BMS is multifactorial. Clinical studies implicate multiple
factors comprising clinical demographics such as insulin-
requiring diabetes mellitus, renal failure, pharmacotherapeutic
conditions (pre-procedural thienopyridine administration
and inconsistent antiplatelet drug use), angiographic lesion
characteristics (greater burden of coronary atherosclerosis),
and interventional procedure-related factors (smaller ﬁnal
stent minimal lumen diameter) as predictors of early
ST (8,9). However, the histopathology of early ST has not
been well characterized, especially in the setting of ACS.
Therefore, the present study sought to determine the
morphologic predictors of early ST, using human autopsy
hearts retrieved from patients presenting with ACS and
dying within 30 days following stent implantation.ﬁbroatheromaMethods
Lesion selection and histology processing. All cases with
stent implantation in coronary arteries were retrospectively
reviewed from our autopsy stent registry obtained from
medical examiners and hospital based pathologists submit-
ted in diagnostic consultation between the years 2004 and
2012. Consecutive cases presenting with ACS and dying
within 30 days following stent placement were selected and
analyzed in this study. The lesions with stents implanted for
>30 days, stenting of nonculprit lesions, stents deployed in
saphenous vein grafts, and repeat stenting due to early ST
were excluded from the analysis (Fig. 1).
Clinical information regarding patient characteristics and
disease conditions were acquired from medical examiners and
submittinghospital based pathologists at autopsy.Thehospital
records and catheterization laboratory reports were available
in a limited number of cases (21 cases). A total of 67 lesions
from 59 patients were analyzed to determine the histopatho-
logic characteristics related to ST. ST was deﬁned as platelet-
rich thrombus that occupied >30% of the cross-sectional
area of the lumen (10). The stented arteries were processed
as previously described (11). A total of 551 cross sections of
stented coronary arteries were histologically evaluated. The
nonstented coronary arteries proximal and distal to the stented
segment and distal myocardium were also assessed (12).
Determination of cause of death. The cause of death was
determined after careful review of patients’ medical history,
available catheterization laboratory reports and evaluation of
histopathologic ﬁndings. Stent-related cause of death was
deﬁned as death directly attributable to the implanted stent
(any adverse event secondary to stent implantation) with or
without evidence of myocardial ischemia in the supplying
territory (e.g., ST or secondary dissections resulting in
acute ischemia, coronary vessel rupture, and embolic phe-
nomenon). Non–stent-related cardiac death was deﬁned asdeath attributable to nonstented
severe coronary artery disease or
noncoronary causes of cardiac
failure (e.g., heart failure) with or
without evidence of myocardial
ischemia. Noncardiac death was
deﬁned as death attributable to
noncardiac causes from organ or
multiorgan failure (e.g., stroke,
kidney failure, infection) or un-
natural death.
Histomorphological assessment
of factors associated with early
ST. The type of underlying pla-
que was classiﬁed according to
the modiﬁed American Heart
Association classiﬁcation (13).
Morphometric measurements of
underlying plaque and medial
wall characteristics were deter-
mined as previously described
(11). Sections with side branch >1 mm diameter were
excluded only for morphometric measurements.
The following histomorphometric parameters were
measured to examine the underlying causes of ST: % struts
penetrating into necrotic core (NC) per section, NC area,
depth of strut penetration into NC; % struts associated with
medial tear per section, medial tear length, medial tear arc; %
struts with incomplete apposition per section, incomplete
apposition area (area between stent struts and underlying
arterial wall), and incomplete apposition distance. To identify
an association between the underlying thrombus related
to the occurrence of ACS (“index thrombus”) the section
with the maximal underlying thrombus was selected and
the maximal thickness of underlying index thrombus was
measured in mm bymorphometry.Medial tear was deﬁned as
complete separation of the media in the stented segment.
In the nonstented regions of the native coronary arteries,
proximal and distal to the stented segment, the presence of
severe stenosis (75% cross-sectional luminal narrowing)
and NC prolapse (uncovered ruptured NC), and extent of
medial dissection and intimal tears, were also recorded.
Statistical analysis. Valueswere expressed asmean SD for
continuous values and as median (interquartile range) for
discrete values. Normality of distribution was tested with
the Shapiro-Wilk test. Non-normally distributed variables
were either log transformed to normal or compared between
groups with theWilcoxon rank sum test. Categorical data was
analyzed by chi-square test or Fisher exact test. For per-
patient or per-lesion analysis, comparison between groups
was performed by Student t test. For per-section analysis,
comparison between groups was performed by linear gener-
alized estimating equation (GEE) modeling with an assumed
Gaussian distribution, an identity link function, and an
assumed AR(1) structure for the within-cluster correlation
matrix in consideration of the clustered nature of 1
Figure 1 Lesion Selection Scheme
ACS ¼ acute coronary syndrome(s); BMS ¼ bare-metal stent(s); DES ¼ drug-eluting stent(s); ST ¼ stent thrombosis.
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2512consecutive sections measured from each lesion (14). Com-
parison of each pair of groups was on the basis of the estimated
marginal means with sequential Bonferroni correction. For
GEE with an assumed binomial distribution, a logistic link
function, and an AR(1) structure in the correlation matrix
was used to assess binomial data. To identify risk factors of
ST within our given set of autopsy data, univariate regression
analysis was performed with ST as binary response variable.
Once signiﬁcant parameters were found, they were entered
into a stepwise multivariate logistic regression analysis
model to investigate independent risk factors. Factors entered
into the multivariate model included underlying lesion
morphology, maximal depth of strut penetration, % strut with
medial tear, and % strut with incomplete apposition. In order
to account for intracluster effects of multiple measurements
within a given subject, GEE modeling was applied as previ-
ously described. All analyses were performed with the SPSS
software (version 19, IBMCorporation, Armonk, New York)
and JMP5 (SAS Institute, Cary, North Carolina). All re-
ported p Values were determined by 2-sided analysis and
values of <0.05 were regarded as statistically signiﬁcant.Results
Patient demographics. Early ST was identiﬁed in 37
lesions from 34 patients whereas no evidence of ST wasobserved in the remaining 25 patients at autopsy. There was
no signiﬁcant difference in age, sex, indication for PCI, and
past medical history between patients with and without ST
(Table 1). Information about antiplatelet medication at the
time of patients’ demise was available in 34 of 59 patients
(Table 1). All of the 34 patients with early ST died of stent-
related death. Of 25 patients without ST, causes of death
were stent-related death in 3 patients, non–stent-related
cardiac death in 17 patients, and noncardiac death in 3
patients. Stent-related death in the absence of ST was
observed secondary from distal dissection (n ¼ 1), coronary
perforation (n ¼ 1), and side branch occlusion secondary to
stenting (n ¼ 1) (Online Table 1). Myocardial examination
revealed 12 cardiac ruptures (6 patients with early ST and 6
patients without early ST). The electrocardiogram readings
at the time of diagnosis showed ST-segment elevation
myocardial infarction in 16 patients and non–ST-segment
elevation myocardial infarction in 13 patients (Table 1). In 2
patients without early ST, a cardiac cause of death could not
be determined as myocardial tissue was not available for
diagnostic consultation. In the present study, pathological
information regarding the myocardium was available in 33 of
59 patients, and all 33 had myocardial infarction by histo-
logic examination (Table 1). In the thrombosis group (all
stent-related death; n ¼ 17 had myocardium examined
histologically), there were 11 patients with transmural
Table 1 Patient Demographics
Thrombosis
(n ¼ 34)
Patent
(n ¼ 25) p Value
Age, yrs 65  11 65  13 0.91
Male 22 (65) 17 (68) >0.99
Indication for PCI
Unstable angina 1 (3) 3 (12) 0.30
Acute myocardial
infarction
33 (97) 22 (88)
Clinical:
STEMI/NSTEMI*
12 (57)/9 (43) 4 (50)/4 (50)
Histologic:
Transmural/
nontransmural MIy
11 (65)/6 (35) 11 (69)/5 (31)
Medical history
Hypertension 17 (50) 13 (52) >0.99
Diabetes mellitus 10 (29) 6 (24) 0.77
Dyslipidemia 15 (44) 8 (32) 0.42
Smoking 6 (18) 8 (32) 0.23
Prior myocardial
infarction
12 (35) 6 (24) 0.40
Prior CABG 3 (9) 3 (12) 0.69
Number of diseased
coronary vessel
2 (1–3) 2 (2–3) 0.22
Renal failure 3 (9) 3 (12) 0.69
Antiplatelet
therapyz
Dual 16/18 (89) 12/16 (75) 0.39
ASA alone 2/18 (11) 4/16 (25)
Unknown 16 10
Cause of deathx
Stent-related
death
34/34 (100) 3/23 (13)k <0.001
Non–stent-related
cardiac death
0/34 (0) 17/23 (74)
Noncardiac death 0/34 (0) 3/23 (13)
Values are mean  SD, n (%), or median (interquartile range). *Clinical information regarding the
electrocardiogram at the time of diagnosis was available in 29 of 59 patients. yPathological in-
formation regarding the myocardium was available in 33 of 59 patients because the diagnostic
consulting cases without myocardium were submitted in our stent registry. zLatest prescription at
the time of patient’s demise. xIn 2 cases without early stent thrombosis, a cardiac cause of death
could not be determined as myocardium was not available. kThree cases were distal dissection,
coronary perforation, and side branch occlusion for secondary to stenting.
ASA ¼ acetylsalicylic acid; CABG ¼ coronary artery bypass graft; MI ¼ myocardial infarction;
NSTEMI ¼ non–ST-segment elevation myocardial infarction; PCI ¼ percutaneous coronary inter-
vention; STEMI ¼ ST-segment elevation myocardial infarction.
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2513myocardial infarction, whereas 6 had subendocardial infarc-
tion. In the patent group (only 3 had stent-related death;
n ¼ 16 had myocardium examined histologically) only 1
patient dying of stent-related death had transmural
myocardial infarction (Table 1).
Lesion characteristics. Table 2 summarizes lesion charac-
teristics stratiﬁed by the presence (n ¼ 37) or absence of
thrombosis (n ¼ 30) within the stented segment. There were
no signiﬁcant differences in stent location in the coronary
tree and stent implant duration (i.e., time from stent
deployment to death) between thrombosed and patent le-
sions. The incidence of ST was not different between stent
types (BMS vs. DES, p ¼ 0.62; sirolimus-, paclitaxel-,
zotarolimus-, and everolimus-eluting stents, p ¼ 0.71)
(Table 2).The presence of NC prolapse was identiﬁed in 70% of
thrombosed lesions compared with 43% in patent lesions
(p ¼ 0.045). The incidence of medial tear was similar in
these groups (thrombosis 49% vs. patent 60%, p ¼ 0.46).
There were 9 lesions with stents implanted in the main
branch that covered minor side branches (1 to 2 mm).
Occlusive thrombus formation in the side branch was
signiﬁcantly more frequent in the thrombosis group com-
pared to the patent group (thrombosis 22% vs. patent 3%,
p ¼ 0.035). Furthermore, there were 7 cases involving true
bifurcation stenting where a 2-stent technique was used and
the frequency of bifurcation stenting was similar between ST
and patent lesions (p < 0.99) (Table 2). There were 3 cases
of false lumen stenting secondary to medial dissection and all
resulted in acute/subacute ST and were allocated to the
thrombosis group. The maximal thrombus thickness at the
site of greatest thrombus burden was signiﬁcantly greater in
the thrombosis compared to the patent group (thrombosis
0.22 mm vs. patent 0.07 mm, p ¼ 0.001).
In the nonstented segments proximal and distal to the
stented segment, severe stenosis (>75% cross-sectional area
narrowing), NC prolapse, medial dissection, and intimal tear
were observed not uncommonly with a higher incidence seen
in arteries with thrombosis than in patent arteries (Table 2).
In addition, major medial dissection, which was deﬁned as
severe luminal narrowing due to medial dissection (throm-
bosis 8% vs. patent 0%, p ¼ 0.25), and minor medial
dissection (thrombosis 43% vs. patent 30%, p ¼ 0.32) were
not signiﬁcantly different. Intimal tears were also frequent
and not signiﬁcantly different (thrombosis 38% vs. patent
40%, p > 0.99).
Per sectional analysis of histomorphological features
associated with early ST. A total of 551 cross sections
from 67 stented lesions were classiﬁed into 3 groups: (A)
sections with presence of thrombosis within ST lesions
(n ¼ 124); (B) sections without thrombosis within ST le-
sions (n ¼ 175); and (C) sections without thrombosis
within patent lesions (n ¼ 252). Morphometric assessment
revealed that the extent of NC prolapse (% struts penetrating
into the NC, NC area, and depth of strut penetration into
NC), medial tear (% struts with medial tear, medial tear
length, and medial tear arc), and incomplete apposition
(% struts with incomplete apposition, incomplete apposition
area, incomplete apposition distance) were signiﬁcantly
higher in sections with thrombus compared to patent sec-
tions (Table 3). Of 124 sections with thrombus, 73% were
associated with at least 1 of the following features: NC
prolapse (28%), medial tear (27%), or incomplete apposition
(34%), whereas only 38% of 427 sections without throm-
bosis had similar features (Figs. 2 to 4). To examine the role
of culprit lesion pathology in early ST of patients pre-
senting with ACS, we identiﬁed culprit sections within the
underlying lesions (rupture, erosion, and calciﬁed nodule)
and nonculprit sections (thin-cap ﬁbroatheroma [TCFA]/
ﬁbroatheroma and pathologic intimal thickening/ﬁbrous/
ﬁbrocalciﬁc). NC prolapse, medial tear and incomplete strut
Table 2 Lesion Characteristics
Thrombosis
(n ¼ 37 Lesions)
Patent
(n ¼ 30 Lesions) p Value
Number of sections 299 252
Number of excluded
morphometric
measurements
33 30
Vessel
LM 1 (3) 1 (3) 0.48
LAD 18 (49) 20 (67)
LCx 5 (14) 2 (7)
RCA 13 (35) 7 (23)
Location
Proximal, % 19 (51) 19 (63) 0.44
Mid, % 14 (38) 7 (23)
Distal/branch, % 4 (11) 4 (13)
Underlying ﬁndings of
implanted stent
Plaque rupture 26 (70) 17 (56) 0.35
Erosion 7 (19) 6 (20)
Calciﬁed nodule 4 (11) 7 (23)
Implant duration, day
<24 h, % 8 (22) 9 (30) 0.27
1–7 days, % 18 (49) 17 (57)
8–30 days, % 11 (30) 4 (13)
Total stented length, mm 27.6  18.8 25.4  14.2 0.58
Number of stents 1 (1–2) 1 (1–2) 0.41
BMS, % 18 (49) 12 (40) 0.62
DES, % 19 (51) 18 (60)
SES* 5 7 0.71
PES* 12 8
ZES 1 2
EES 1 1
Continued in the next column
Table 2 Continued
Thrombosis
(n ¼ 37 Lesions)
Patent
(n ¼ 30 Lesions) p Value
Stented segment
EEL areay, mm2 14.0  6.0 13.7  7.0 0.87
Lumen areay, mm2 6.5  2.6 6.8  3.1 0.71
Underlying plaque areay,
mm2
7.5  4.0 7.0  4.4 0.62
Stent areay, mm2
Mean 6.4  2.4 6.7  3.1 0.70
Max 7.9  2.8 8.3  4.1 0.58
Min 5.0  2.3 5.0  2.5 0.99
Maximal index
thrombus
thickness, mm
0.22 (0.14–0.49) 0.07 (0.00–0.17) 0.001
NC prolapse 26 (70) 13 (43) 0.045
Bifurcation stenting 4 (11) 3 (10) <0.99
Side branch occlusion 8 (22) 1 (3) 0.035
False lumen stenting 3 (8) 0 (0) 0.25
Nonstented segment
Stenosis >75%z
Proximal 4 (11) 3 (10) <0.99
Distal 11 (30) 6 (20) 0.41
NC prolapse
Proximal 2 (5) 1 (3) <0.99
Distal 1 (3) 0 (0) <0.99
Medial dissection 18 (49) 9 (30) 0.14
Proximal þ distal 3 (8) 4 (13)
Proximal 4 (11) 1 (3) 0.20
Distal 11 (30) 4 (13)
Majormedialdissectionx 3 (8) 0 (0) 0.25
Minor medial dissection 16 (43) 9 (30) 0.32
Intimal tear 14 (38) 12 (40) >0.99
Proximal þ distal 3 (8) 4 (13)
Proximal 6 (16) 2 (7) 0.54
Distal 5 (14) 6 (20)
Values are n (%), mean  SD, and median (interquartile range). *One stented lesion contained
SES and PES. ySections at branch points were excluded from morphometric measurements.
zCross-sectional % area stenosis in native nonstented coronary artery. xMajor medial dissection
was deﬁned as severe luminal narrowing due to medial dissection.
BMS ¼ bare-metal stent(s); DES ¼ drug-eluting stent(s); EEL ¼ external elastic lamina; EES ¼
everolimus-eluting stent(s); LAD¼ left anterior descending coronary artery; LCx¼ left circumferential
coronary artery; LM¼ left main coronary artery; NC¼ necrotic core; PES¼ paclitaxel-eluting stent(s);
RCA ¼ right coronary artery; SES ¼ sirolimus-eluting stent(s); ZES ¼ zotarolimus-eluting stent(s).
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2514apposition were shown to be independently associated with
the occurrence of ST. In detail, the maximal depth of strut
penetration, the percent of struts with medial tear and the
percent of struts with incomplete apposition were signiﬁ-
cantly and independently related to ST. There was a sig-
niﬁcant difference in the underlying pathology of the
diseased artery (p < 0.001), with rupture more commonly
observed in sections with presence of ST (Table 4).Discussion
The present autopsy study examined the histopathological
causes of early ST in patients experiencing ACS. In this
regard, the most salient ﬁndings of the current study can be
summarized as follows: 1) prolapse of NC was signiﬁcantly
greater in thrombosed compared to patent lesions; 2) plaque
rupture as precedent of ACS was signiﬁcantly greater in
sections with thrombosis compared to patent sections; and
3) the extent of NC prolapse, medial tear, and incomplete
strut apposition were signiﬁcantly greater in thrombosed
compared to patent sections. NC prolapse, medial tear, and
incomplete strut apposition were independent risk factors
associated with ST.Relationship of underlying plaque morphologies to early
ST. Clinical intracoronary imaging studies have reported
that the underlying plaque morphology inﬂuences the
outcome following PCI. Porto et al. (15) demonstrated in
patients presenting with non–ST-segment elevation myocar-
dial infarction or stable angina that the presence of underlying
TCFA prior to stenting and intrastent thrombus as assessed
by optical coherence tomography (OCT) were related to
periprocedural myocardial infarction. In the current autopsy
study, the underlying plaque morphology was not found to be
an independent predictor of early ST owing to the abundant
presence of plaque rupture in the setting of ACS patients with
an inherent selection bias for adverse events.
NC PROLAPSE. NC is known to be highly thrombogenic as
compared to other components of atherosclerotic plaque,
Table 3 The Impact of NC Prolapse, Medial Tear, and Incomplete Apposition on Early Stent Thrombosis
Thrombosis (n ¼ 37 Lesions) Patent (n ¼ 30 Lesions)
p Value
(A) Section With Thrombus
(n ¼ 124)
(B) Section Without Thrombus
(n ¼ 175)
(C) Section Without Thrombus
(n ¼ 252)
Underlying disease
Rupture, % 35 (28) 15 (9) 28 (11) <0.001
Erosion, % 3 (2) 4 (2) 6 (2)
Calciﬁed nodule, % 3 (2) 0 (0) 10 (4)
TCFA/ﬁbroatheroma, % 15 (12) 42 (24) 75 (30)
PIT/ﬁbrous/ﬁbrocalciﬁc, % 68 (55) 114 (65) 133 (53)
Necrotic core prolapse
Number of sections with necrotic core prolapse, % 33 (28)yz 18 (10) 28 (11) <0.001
% strut penetrating into necrotic core* 7.8  14.8yz 2.3  8.3 1.9  5.7 <0.001
Necrotic core area,* mm2 0.72  1.66yz 0.13  0.55 1.3  0.55 <0.001
Mean depth of strut penetration,* mm 88.1  208.3yz 15.5  62.3 10.7  38.9 <0.001
Maximal depth of strut penetration,* mm 114.4  27.6yz 20.7  87.8 11.5  41.9 <0.001
Medial tear
Number of sections with medial tear, % 31 (27) 16 (9) 50 (20) 0.004
% strut with medial tear* 10.2  19.0y 1.9  6.4 3.9  8.7 0.015
Medial tear length,* mm 0.71  1.42y 0.08  0.29 0.27  0.62 0.017
Medial tear arc,*  26.3  52.9y 2.9  9.8 8.3  19.5 0.020
Incomplete apposition
Number of sections with incomplete apposition 40 (34)yz 33 (18) 45 (18) 0.008
% strut with incomplete apposition* 0.14  0.23yz 0.06  0.14 0.05  0.11 <0.001
Incomplete apposition area,* mm2 0.52  1.34y 0.11  0.30 0.08  0.27 0.010
Mean incomplete apposition distance,* mm 153.9  34.4y 45.0  12.1 42.5  9.8 0.001
Maximal incomplete apposition distance,* mm 20.4  45.7y 5.38  13.8 5.08  11.9 0.001
Values are n (%) or mean  SD. Sections at branch points were excluded from morphometric measurements. *Data was log transformed for the statistical calculation. ySigniﬁcantly different from (B).
zSigniﬁcantly different from (C).
NC ¼ necrotic core; PIT ¼ pathologic intimal thickening: TCFA ¼ thin-cap ﬁbroatheroma.
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2515and the thrombogenicity is even ampliﬁed as the blood
contacting surface area increases (16). This has been
corroborated by both pathologic and intravascular ultra-
sound (IVUS) studies demonstrating that intrastent plaque
material protrusion was associated with early ST (17,18).
Choi et al. (17) showed that the maximal intrastent tissue
protrusion area and volume by IVUS were predictors of early
ST. Our current histologic study is in clear agreement with
these observations as deeper strut penetration as well as
presence of larger NC were both determinants of early ST.
This further emphasizes the need for accurate recognition of
the size and extent of NC content in the underlying plaque
in order to determine treatments that will either passivate or
prevent this thrombotic milieu from occurring.
MEDIAL TEAR. To date, the association of intrastent medial
tear with early ST has not been reported in clinical or
pathological studies. In the clinical setting of unstable pla-
que, we are unaware of instances where intrastent medial
tear has been reported to trigger thrombosis after stenting.
This may likely be explained by the fact that current
angiographic imaging modalities lack the capability to assess
medial wall and plaque morphology after deployment of
balloon-expandable stents. An important ﬁnding of our
study was that medial tear length rather than the pure
incidence of medial tear within the stented segment was
signiﬁcantly associated with the occurrence of early ST.This phenomenon is explained by the different level of
analysis (lesion-based vs. section-based analysis) owing to
the fact that dynamic measurements such as medial tear
length can only be assessed on a cross-sectional level and
may be more predictive of ST than lesional assessment.
On the other hand, the presence of medial dissection and
intimal tears within the nonstented proximal/distal seg-
ments was 49% and 38%, respectively, in ACS culprit le-
sions and not signiﬁcantly different among thrombosed
and patent lesions. These ﬁndings are in contradiction to
clinically studies that have suggested that intimal edge dis-
sections is most relevant for the occurrence of early ST
(17–19). However, inability to distinguish intimal tears from
true medial dissection with current intravascular imaging
techniques may help to explain this contradiction.
Additional support for this view can be derived from
human autopsy studies that have shown that not only NC,
but also vascular smooth muscle cells (SMCs) and adven-
titial tissue, are important sources of tissue factor, the major
component responsible for triggering the extrinsic pathway
of coagulation (20,21). Furthermore, animal studies have
reported that vascular injury induced a rapid increase in
tissue factor expression in the media and adventitia, with
enhanced thrombogenicity (22,23). We demonstrated that
medial tear was an important risk factor of early ST.
Thrombosis may ensue when a large amount of tissue factor
Figure 2 Histology of Early Stent Thrombosis Related to NC Prolapse
A 69-year-old woman patient presented with acute myocardial infarction (AMI). After successful implantation of a bare-metal stent in the left anterior descending coronary artery
(LAD), the patient experienced pulseless electrical activity and died. Left column shows postmortem X-ray revealing moderate calciﬁcation. Middle column shows low-power
photomicrographs of cross-sectional histology in the stented coronary segment. The stent is deployed in a ruptured plaque with a large necrotic core (NC). Stent struts
(asterisks) are embedded deeply into NC. Right column shows high-power images of the insets of mid column, demonstrating strut penetration into NC and thrombus
(Thr) formation in the lumen. Caþþ ¼ calciﬁcation.
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2516is released into the blood from the adventitia or from medial
SMCs following medial tear from excessive injury during
stenting (24). An alternative hypothesis refers to the pro-
inﬂammatory environment induced by SMC injury resulting
in release of tissue factors and other pro-coagulants. Thrombin
and platelet-derived growth factor cause SMCs to produce
interleukin 6, leading to hepatic synthesis of pro-coagulant
proteins such as ﬁbrinogen and plasminogen activator inhib-
itor 1 (25,26). As a result, local stimulation of SMCs in the
arterial wall may augment the inﬂammatory response and
promote a pro-coagulant state within the arterial wall.
INDEX THROMBUS BURDEN. A number of clinical studies
have shown a signiﬁcant association between underlying
thrombus burden in the setting of ACS and the occurrence
of acute ST and/or incomplete apposition (17,27,28). The
putative explanation of this phenomenon pertains to an
underestimation of true vessel size by angiography in thepresence of thrombus. As the thrombus organizes over time,
incomplete apposition may be observed. The current autopsy
study supports this hypothesis by establishing an association
between underlying thrombus burden and the occurrence of
ST, whereas a direct association with incomplete apposition
could not be shown owing to the single time-point analysis
of all autopsy studies. Whereas incomplete apposition was
reported to be a risk factor for the occurrence of late ST at
autopsy, this association remains controversial in the clinical
setting.
Impact of suboptimal stenting on early ST. Angiographic
and IVUS studies have suggested that the presence of re-
sidual edge dissection and signiﬁcant stenosis in proximal
and/or distal reference segments can increase the risk of early
ST (7,17–19,29). The results of the current study are in
agreement that signiﬁcant edge stenosis may substantially
increase the risk of early ST, whereas no causal relationship
Figure 3 Histology of Early Stent Thrombosis Related to Medial Tear
A 37-year-old man patient received sirolimus-eluting stents in the bifurcation of the LAD and diagonal branch for AMI. Seven days later, the patient presented to the emergency
room with chest pain followed by cardiac arrest. Left column shows postmortem X-ray revealing absence of calciﬁcation. Middle column shows low-power photomicrographs of
cross-sectional histology in the stented coronary segment illustrating that the stents are deployed in an early-stage plaque (pathologic intimal thickening or early ﬁbroatheroma).
Stent struts (asterisks) are well apposed to the vessel wall. Right column shows high-power images of the insets of middle column, demonstrating medial tear (arrowheads)
and thrombus (Thr) formation in the multiple sections. Diag ¼ diagonal branch; Med ¼ media; other abbreviations as in Figure 2.
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2517was noted for intimal edge dissections. However, the limited
number of lesions with relevant intimal edge dissections may
have precluded from detecting signiﬁcant association. On
the other hand, a clear incremental risk of early ST was
noted for medial tear within the stented lesion, suggesting a
better understanding of plaque morphology is needed in
these patients. Our study further suggests that the severity of
damage rather than its mere presence is relevant to throm-
bosis following stent implantation.
A clinical study of 20 acute myocardial infarction patients
reported incomplete stent coverage of the culprit plaques
(uncovered rupture/TCFA) occurred in 50% of patients
treated by angiography-guided PCI (30), and studies
using near-infrared spectroscopy proposed that failure to
completely seal the NC may result in early ST (31). A similar
trend was also noted in our current pathology study pointing
towards a need to cover the entire length of NC. In our study,
NC prolapse in the nonstented segment was observed in 4
lesions, however, due to the limited number of lesions, this
did not reach statistical signiﬁcance (Table 2).
Our study further illustrated the importance of appro-
priate stenting; whereas complete stent apposition may beimportant to avoid incomplete apposition in rupture-prone
lesions, excess medial tear secondary to high inﬂation pres-
sure was found to be a major determinant of early ST.
Owing to an increasing number of younger patients pre-
senting with ACS, the ﬁndings of the current pathology
study clearly suggest the use of intravascular imaging prior to
stent implantation may be important. On the basis of our
ﬁndings and the selected use of intravascular imaging in
ACS patients, tailored interventional therapeutic approaches
may be feasible.
Incomplete apposition and incomplete expansion. In
clinical studies, the incidence of incomplete stent apposi-
tion in lesions with early ST was reported to range widely,
from 9% to 58% with IVUS; because of the wide range,
the true impact of incomplete apposition remains unclear
(7,17,18,29,32); however, our study suggests that this is
an important factor. A clinical study of everolimus-eluting
bioresorbable scaffolds demonstrated that incompletely
apposed struts detected by OCT were more frequently
accompanied by intraluminal masses than apposed struts
even at 6 months following stenting (33), indicating the
association between incomplete strut apposition and ST.
Figure 4 Histology of Early Stent Thrombosis Related to Incomplete Apposition
An 80-year-old woman patient received 2 bare-metal stents in the LAD for AMI. Four days later, the patient presented with chest pain followed by cardiac arrest. Upper row shows
low-power photomicrographs of cross-sectional histology in the stented coronary segment illustrating that the stents are deployed in a heavily calciﬁed (Caþþ) plaque. Several
stent struts (asterisks) are incompletely apposed to the vessel wall. Lower row shows high-power images of the insets of upper row conﬁrming the presence of incomplete
apposition (double-head arrows) and thrombus (Thr) formation. Abbreviations as in Figure 2.
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2518In the same scenario, in vitro studies in a blood perfusion
model using silicone loops elucidated increased thrombo-
genicity in incompletely apposed metal struts compared to
the apposed counterparts, and this result was validated by
shifting ﬂow patterns in computational models (34). This
study reported 2 important ﬁndings: no ordinal correlation
between the incomplete apposition distance and thrombo-
genicity; and decreased thrombogenicity in DES with a
polymer coating compared to BMS. In the current study, the
proportion of incompletely apposed struts was a signiﬁcant
ﬁnding associated with the provocation of thrombosis, with
the thrombus attached to the strut surface (Fig. 4). There-
fore, we hypothesize that the inherent thrombogenic prop-
erty of surface materials contacting blood, in combination
with the rheology of blood ﬂow changes induced by the
struts, may be a potent determinant of thrombosis. Further
study by high resolution imaging modality such as OCT
may be needed to conﬁrm these ﬁndings in the clinical
setting.
Previous studies report that stent expansion, deﬁned as
the ratio of minimal stent area to nonstented reference
luminal area, is also a determinant of early ST in BMS and
DES (18,29). In the current study the limited number of
cases precludes us from assessing differences between DES
and BMS. Abnormal shear stress by geometric aberration
has been suggested as an inducer of thrombosis but the
precise mechanism remains undetermined. More recently,other investigators have shown no relevant difference in
stent expansion among cases with and without early ST
(17,35). This may be explained by continued improvement
of interventional devices, aggressive use of intracoronary
imaging devices in the catheterization laboratory, and further
reﬁnement in anticoagulant regimens. In the current study,
stent expansion in reference to proximal nonstented segment
could not be assessed due to the shrinkage of nonstented
coronary arteries during ﬁxation and histologic processing
(36). Therefore, the impact of stent expansion could not be
determined in the present study.
Study limitations. The results of our study are derived
from patients dying following interventional treatment after
initial stenting, which may not necessarily be applicable to
patients who received interventional treatment for ST and
survived. Nevertheless, our analysis included a cohort of
patients where ST was not the cause of death within 30 days,
therefore balancing our ﬁndings. The limited information
about therapeutic conditions, especially the status of dual
antiplatelet therapy and clinical data, may preclude from
understanding other important mechanisms of early ST in
these cases. Despite the consensus of our previous patho-
logical deﬁnition of ST as having a platelet-rich thrombus
occupying >30% of cross-sectional luminal area, a limited
number of ST cases submitted to our institution may have
fallen below this threshold. Nevertheless, the previous and
current pathological deﬁnition of ST warrants sufﬁcient
Table 4 Univariate and Multivariate Analysis of Histomorphometric Parameters as Determinants of Early Stent Thrombosis
Univariate Model Multivariate Model
Odds Ratio
(95% CI) p Value
Odds Ratio
(95% CI) p Value
Underlying disease
Rupture, % 2.2 (1.5–3.2) <0.001 1.1 (0.5–2.4) 0.77
Erosion, % 1.2 (0.5–2.9) 0.69 0.7 (0.2–2.5) 0.61
Calciﬁed nodule, % 1.8 (0.8–3.9) 0.17 1.6 (0.7–3.8) 0.25
TCFA/ﬁbroatheroma, % 0.8 (0.6–1.2) 0.32 0.7 (0.5–1.0) 0.064
PIT/ﬁbrous/ﬁbrocalciﬁc, % Reference Reference
Necrotic core prolapse
% strut penetrating into necrotic core* 1.8 (1.4–2.2) <0.001
Necrotic core area*, mm2 2.4 (1.8–3.3) <0.001
Mean depth of strut penetration*, mm 2.2 (1.7–2.9) <0.001
Maximal depth of strut penetration*, mm 2.3 (1.8–3.1) <0.001 2.3 (1.3–4.3) 0.006y
Medial tear
% strut with medial tear* 1.6 (1.2–2.1) 0.003 1.8 (1.3–2.4) 0.001
Medial tear length*, mm 1.7 (1.2–2.5) 0.004
Medial tear arc*,  1.7 (1.2–2.4) 0.004
Incomplete apposition
% strut with incomplete apposition* 1.6 (1.3–2.0) <0.001 1.8 (1.4–2.4) <0.001z
Incomplete apposition area*, mm2 2.2 (1.5–3.4) <0.001
Mean incomplete apposition distance*, mm 1.9 (1.5–2.6) <0.001
Maximal incomplete apposition distance*, mm 1.9 (1.4–2.5) <0.001
*Data was log transformed for the statistical calculation. yMaximal depth of strut penetration has the lowest p Value (1.9  10–9) in the necrotic core prolapse group by univariate analysis. The p Values of %
strut penetrating into necrotic core, necrotic core area, and mean depth of strut penetration were 9.9  10–8, 1.6  10–8, and 5.4  10–9, respectively. zPercent strut with incomplete apposition has the
lowest p Value (5.4  10–6) in the incomplete apposition group by univariate analysis. The p Values of incomplete apposition area, mean incomplete apposition distance, and maximal incomplete apposition
distance were 2.1  10–4, 7.1  10–6, and 6.5  10–6, respectively.
CI ¼ conﬁdence interval; PIT ¼ pathologic intimal thickening: TCFA ¼ thin-cap ﬁbroatheroma.
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2519certainty that the patients’ demises were stent related.
Within the given set of data, a speciﬁed analysis of histo-
pathologic features pertaining to differences among stent
types was beyond the scope of the current study because of
limited number of cases. However, our study revealed that
histological features such as NC prolapse, medial tear, and
incomplete apposition are important substrates for ST
in the limited number of cases available for analysis.
Furthermore, the current multivariate analysis might be
slightly overﬁtted by conventional standards; nevertheless,
the most signiﬁcant ﬁndings of our study were entered into
this model, and we consider the ﬁndings as relevant and
valid. Further clinical studies are required to conﬁrm the
signiﬁcance and application of our ﬁndings in a larger
cohort because the present study was limited to autopsy
cases of early ST.
Conclusions
Our autopsy study revealed that underlying thrombus burden
and suboptimal stenting leads to greater NC disruption,
medial tear, and incomplete apposition, which are important
factors in the induction of early ST. In contrast to the general
perception that early ST may be regarded a mechanical
failure of stent implantation, the current pathology study
introduces a more differential view on the occurrence of early
ST, including different biological mechanisms depending on
the underlying plaque morphology. Further reﬁnement ofinterventional devices and procedural modiﬁcation may be
required to improve clinical outcomes in patients presenting
with ACS and the type of underlying plaque morphology for
treatment with stenting.
Address correspondence to:Dr. Renu Virmani, CVPath Institute,
Inc., 19 Firstﬁeld Road, Gaithersburg, Maryland 20878. E-mail:
rvirmani@cvpath.org.REFERENCES
1. Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused
update of the guideline for the management of patients with unstable
angina/non-ST-elevation myocardial infarction (updating the 2007
guideline and replacing the 2011 focused update): a report of the
American College of Cardiology Foundation/American Heart Asso-
ciation Task Force on Practice Guidelines. J Am Coll Cardiol 2012;60:
645–81.
2. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA
guideline for the management of ST-elevation myocardial infarction: a
report of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines. J Am Coll
Cardiol 2013;61:e78–140.
3. Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the
management of acute coronary syndromes in patients presenting
without persistent ST-segment elevation: the Task Force for the
management of acute coronary syndromes (ACS) in patients presenting
without persistent ST-segment elevation of the European Society of
Cardiology (ESC). Eur Heart J 2011;32:2999–3054.
4. Steg PG, James SK, Atar D, et al. ESC guidelines for the management
of acute myocardial infarction in patients presenting with ST-segment
elevation. Eur Heart J 2012;33:2569–619.
Nakano et al. JACC Vol. 63, No. 23, 2014
Pathology of Early Stent Thrombosis June 17, 2014:2510–20
25205. Kukreja N, Onuma Y, Garcia-Garcia HM, Daemen J, van
Domburg R, Serruys PW. The risk of stent thrombosis in patients with
acute coronary syndromes treated with bare-metal and drug-eluting
stents. J Am Coll Cardiol Intv 2009;2:534–41.
6. Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month
clinical outcome of thrombotic stent occlusion after bare-metal, siro-
limus, or paclitaxel stent implantation. J Am Coll Cardiol 2005;45:
947–53.
7. Alfonso F, Suarez A, Angiolillo DJ, et al. Findings of intravascular
ultrasound during acute stent thrombosis. Heart 2004;90:1455–9.
8. Aoki J, Lansky AJ, Mehran R, et al. Early stent thrombosis in patients
with acute coronary syndromes treated with drug-eluting and bare
metal stents: the Acute Catheterization and Urgent Intervention Triage
Strategy trial. Circulation 2009;119:687–98.
9. Dangas GD, Claessen BE, Mehran R, et al. Development and vali-
dation of a stent thrombosis risk score in patients with acute coronary
syndromes. J Am Coll Cardiol Intv 2012;5:1097–105.
10. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late
drug-eluting stent thrombosis: strut coverage as a marker of endothe-
lialization. Circulation 2007;115:2435–41.
11. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in
humans: delayed healing and late thrombotic risk. J Am Coll Cardiol
2006;48:193–202.
12. Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R.
Sudden coronary death. Frequency of active coronary lesions, inactive
coronary lesions, and myocardial infarction. Circulation 1995;92:
1701–9.
13. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons
from sudden coronary death: a comprehensive morphological classiﬁ-
cation scheme for atherosclerotic lesions. Arterioscler Thromb Vasc
Biol 2000;20:1262–75.
14. Faraway JJ. Mixed effect models for nonnormal responses. In: Faraway
JJ, editor. Extending the Linear Model with R: Generalized Linear,
Mixed Effects and Nonparametric Regression Models. Boca Raton,
FL: Chapman and Hall/CRC, 2005:201–10.
15. Porto I, Di Vito L, Burzotta F, et al. Predictors of periprocedural
(type IVa) myocardial infarction, as assessed by frequency-domain
optical coherence tomography. Circ Cardiovasc Interv 2012;5:89–96,
S1–6.
16. Fernandez-Ortiz A, Badimon JJ, Falk E, et al. Characterization of the
relative thrombogenicity of atherosclerotic plaque components: impli-
cations for consequences of plaque rupture. J Am Coll Cardiol 1994;23:
1562–9.
17. Choi SY, Witzenbichler B, Maehara A, et al. Intravascular ultrasound
ﬁndings of early stent thrombosis after primary percutaneous inter-
vention in acute myocardial infarction: a Harmonizing Outcomes
with Revascularization and Stents in Acute Myocardial Infarction
(HORIZONS-AMI) substudy. Circ Cardiovasc Interv 2011;4:239–47.
18. Cheneau E, Leborgne L, Mintz GS, et al. Predictors of subacute stent
thrombosis: results of a systematic intravascular ultrasound study.
Circulation 2003;108:43–7.
19. van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of
coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am
Coll Cardiol 2009;53:1399–409.
20. Toschi V, Gallo R, Lettino M, et al. Tissue factor modulates the
thrombogenicity of human atherosclerotic plaques. Circulation 1997;
95:594–9.
21. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of
tissue factor in the normal vessel wall and in the atherosclerotic plaque.
Proc Natl Acad Sci U S A 1989;86:2839–43.
22. Marmur JD, Rossikhina M, Guha A, et al. Tissue factor is rapidly
induced in arterial smooth muscle after balloon injury. J Clin Invest
1993;91:2253–9.23. Baker AB, Gibson WJ, Kolachalama VB, et al. Heparanase regulates
thrombosis in vascular injury and stent-induced ﬂow disturbance. J Am
Coll Cardiol 2012;59:1551–60.
24. Schecter AD, Giesen PL, Taby O, et al. Tissue factor expression in
human arterial smooth muscle cells. TF is present in three cellular
pools after growth factor stimulation. J Clin Invest 1997;100:
2276–85.
25. Kranzhofer R, Clinton SK, Ishii K, Coughlin SR, Fenton JW 2nd,
Libby P. Thrombin potently stimulates cytokine production in human
vascular smooth muscle cells but not in mononuclear phagocytes. Circ
Res 1996;79:286–94.
26. Loppnow H, Libby P. Proliferating or interleukin 1-activated human
vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest
1990;85:731–8.
27. De Luca G, Dirksen MT, Spaulding C, et al. Time course, predictors
and clinical implications of stent thrombosis following primary angio-
plasty. Insights from the DESERT cooperation. Thromb Haemost
2013;110:826–33.
28. Hong YJ, Jeong MH, Choi YH, et al. Clinical, angiographic, and
intravascular ultrasound predictors of early stent thrombosis in pa-
tients with acute myocardial infarction. Int J Cardiol 2013;168:
1674–5.
29. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and re-
sidual reference segment stenosis are related to stent thrombosis after
sirolimus-eluting stent implantation: an intravascular ultrasound study.
J Am Coll Cardiol 2005;45:995–8.
30. Legutko J, Jakala J, Mintz GS, et al. Virtual histology-intravascular
ultrasound assessment of lesion coverage after angiographically-
guided stent implantation in patients with ST elevation myocardial
infarction undergoing primary percutaneous coronary intervention. Am
J Cardiol 2012;109:1405–10.
31. Sakhuja R, Suh WM, Jaffer FA, Jang IK. Residual thrombogenic
substrate after rupture of a lipid-rich plaque: possible mechanism of
acute stent thrombosis? Circulation 2010;122:2349–50.
32. Uren NG, Schwarzacher SP, Metz JA, et al. Predictors and outcomes
of stent thrombosis: an intravascular ultrasound registry. Eur Heart J
2002;23:124–32.
33. Gomez-Lara J, Radu M, Brugaletta S, et al. Serial analysis of the
malapposed and uncovered struts of the new generation of everolimus-
eluting bioresorbable scaffold with optical coherence tomography. J Am
Coll Cardiol Intv 2011;4:992–1001.
34. Kolandaivelu K, Swaminathan R, Gibson WJ, et al. Stent thrombo-
genicity early in high-risk interventional settings is driven by stent
design and deployment and protected by polymer-drug coatings. Cir-
culation 2011;123:1400–9.
35. Okabe T, Mintz GS, Buch AN, et al. Intravascular ultrasound pa-
rameters associated with stent thrombosis after drug-eluting stent
deployment. Am J Cardiol 2007;100:615–20.
36. Siegel RJ, Swan K, Edwalds G, Fishbein MC. Limitations of post-
mortem assessment of human coronary artery size and luminal nar-
rowing: differential effects of tissue ﬁxation and processing on vessels
with different degrees of atherosclerosis. J Am Coll Cardiol 1985;5:
342–6.Key Words: acute coronary syndrome(s) - bare-metal stent(s) -
drug-eluting stent(s) - early stent thrombosis - histopathology.
APPENDIX
For a supplemental table, please see the online version of this article.
